EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis

TamPub

Kuvailutiedot

dc.contributor.author Kokko, Antti -
dc.contributor.author Laiho, Päivi -
dc.contributor.author Lehtonen, Rainer -
dc.contributor.author Korja, Sanna (Tay) -
dc.contributor.author Schleutker, Johanna (Tay) -
dc.date.accessioned 2012-06-17T20:14:10Z
dc.date.available 2012-06-15 16:34:04 -
dc.date.available 2012-06-17T20:14:10Z
dc.date.issued 2006 -
dc.identifier.issn 1471-2407 -
dc.identifier.uri http://tampub.uta.fi/handle/10024/65866
dc.description BioMed Central Open access -
dc.description.abstract Background Ephrin receptor B2 (EPHB2) has recently been proposed as a novel tumor suppressor gene in colorectal cancer (CRC). Inactivation of the gene has been shown to correlate with progression of colorectal tumorigenesis, and somatic mutations have been reported in both colorectal and prostate tumors. Methods Here we have analyzed the EPHB2 gene for germline alterations in 101 individuals either with 1) CRC and a personal or family history of prostate cancer (PC), or 2) intestinal hyperplastic polyposis (HPP), a condition associated with malignant degeneration such as serrated adenoma and CRC. Results Four previously unknown missense alterations were observed, which may be associated with the disease phenotype. Two of the changes, I361V and R568W, were identified in Finnish CRC patients, but not in over 300 Finnish familial CRC or PC patients or more than 200 population-matched healthy controls. The third change, D861N, was observed in a UK HPP patient, but not in additional 40 UK HPP patients or in 200 UK healthy controls. The fourth change R80H, originally identified in a Finnish CRC patient, was also found in 1/106 familial CRC patients and in 9/281 healthy controls and is likely to be a neutral polymorphism. Conclusion We detected novel germline EPHB2 alterations in patients with colorectal tumors. The results suggest a limited role for these EPHB2 variants in colon tumor predisposition. Further studies including functional analyses are needed to confirm this. -
dc.language.iso en -
dc.title EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis -
dc.type fi=Artikkeli aikakauslehdessä | en=Journal article| -
dc.identifier.urn urn:nbn:uta-3-628 -
dc.identifier.doi 10.1186/1471-2407-6-145 -
dc.type.version fi=Kustantajan versio | en=Publisher's version| -
dc.subject.okm fi=Syöpätaudit | en=Cancers| -
dc.journal.title BMC Cancer -
dc.journal.volume 6 -
dc.journal.number 145 -
dc.oldstats 65 -

Viite kuuluu kokoelmiin:

Kuvailutiedot